U.S. Patients Face Growing Number of Foreign Drug Recalls
Some of the drugs available to patients in the United States are made in laboratories overseas. While foreign drugs are required to meet the same rigorous safety standards as medications made in the U.S., many foreign facilities are falling under heavy scrutiny for manufacturing inferior products.
Last week, The Wall Street Journal reported Sun Pharma is recalling roughly 400,000 bottles of antidepressant and antihistamine medications because the products failed to meet quality testing standards. The recall comes on the heels of a similar event, in which Indian drug maker, Lupin, was forced to recall 10,000 bottles of an antibiotic because the medications were contaminated and did not meet purity standards. Experts stated the medications could have resulted in patients suffering antibiotic drug injuries.
These incidents leave many curious as to what they can do to reduce their chances of drug injuries. The drug injury attorneys with Ferrer, Poirot & Wansbrough believe vigilance from both patients and doctors is key. Patients should always research the side effects and recall history of any new medications they take, and any questions or concerns that arise should be discussed with doctors or pharmacists.